Latest Asx Listing News

Regis Resources and Vault Minerals have agreed to merge, creating Australia's third-largest ASX-listed gold producer with over 700,000 ounces annual output and a diversified asset base.

Regis Resources Ltd (ASX:RRL) and Vault Minerals Ltd (ASX:VAU) have agreed to merge via a scheme of arrangement, forming a new senior gold producer with over 700,000 ounces annual production and a market cap near A$10.7 billion.

Corella Resources has issued 205 million shares raising $2.46 million to fund its Chobe Project acquisition and working capital, with a second tranche and attaching options pending shareholder approval.

Delorean Corporation has launched a $2.2 million Share Purchase Plan at $0.09 per share, matching a recent strategic placement to LMS Energy. The capital raise supports construction of key bioenergy projects in South Australia and New South Wales.

Arcadia Minerals (ASX: AM7) has denied possessing any undisclosed information following a sharp rise in its share price and volume. The company retracted parts of a recent market update related to its negotiations with Xinhai Mining Services and confirmed compliance with ASX disclosure rules.

NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.

Beetaloo Energy has secured full underwriting for its $5 million Share Purchase Plan, with shareholder approval for the share issuance and any shortfall shares to be sought at the upcoming AGM on 29 May 2026.

Botala Energy Ltd has denied holding undisclosed information following a sharp share price rise, linking the spike to a recent Serowe CBM Project announcement and confirming compliance with ASX disclosure rules.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) has had its trading suspension lifted as of 4 May 2026, following the lodgement of its delayed Annual Report revealing a $2.86 million net loss.

Athena Resources is raising $3.5 million through a discounted share placement backed by major investors to fast-track drilling and feasibility at its Narryer magnetite project.

Litchfield Minerals denies undisclosed material information behind recent share price jump, pointing to public engagement, media activity, and early-stage exploration sample processing as key influences.

Cynata Therapeutics has secured A$1.5 million through an institutional placement priced at a 22.5% discount, aiming to extend its cash runway ahead of pivotal Phase 3 and Phase 2 trial results expected in May and June 2026.